188 related articles for article (PubMed ID: 30686547)
21. An autocrine VEGF/VEGFR2 and p38 signaling loop confers resistance to 4-hydroxytamoxifen in MCF-7 breast cancer cells.
Aesoy R; Sanchez BC; Norum JH; Lewensohn R; Viktorsson K; Linderholm B
Mol Cancer Res; 2008 Oct; 6(10):1630-8. PubMed ID: 18922978
[TBL] [Abstract][Full Text] [Related]
22. [Effect of AG490 on JAK2/STAT3 signaling pathway in human retinoblastoma HXO-RB44 cell lines].
Xu B; Chen X; Tan J; Xu X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Oct; 43(10):1061-1067. PubMed ID: 30523225
[TBL] [Abstract][Full Text] [Related]
23. Apigenin induces caspase-dependent apoptosis by inhibiting signal transducer and activator of transcription 3 signaling in HER2-overexpressing SKBR3 breast cancer cells.
Seo HS; Ku JM; Choi HS; Woo JK; Jang BH; Go H; Shin YC; Ko SG
Mol Med Rep; 2015 Aug; 12(2):2977-84. PubMed ID: 25936427
[TBL] [Abstract][Full Text] [Related]
24. Phosphorylated VEGFR2 and hypertension: potential biomarkers to indicate VEGF-dependency of advanced breast cancer in anti-angiogenic therapy.
Fan M; Zhang J; Wang Z; Wang B; Zhang Q; Zheng C; Li T; Ni C; Wu Z; Shao Z; Hu X
Breast Cancer Res Treat; 2014 Jan; 143(1):141-51. PubMed ID: 24292957
[TBL] [Abstract][Full Text] [Related]
25. Apatinib Induces Ferroptosis of Glioma Cells through Modulation of the VEGFR2/Nrf2 Pathway.
Xia L; Gong M; Zou Y; Wang Z; Wu B; Zhang S; Li L; Jin K; Sun C
Oxid Med Cell Longev; 2022; 2022():9925919. PubMed ID: 35602105
[TBL] [Abstract][Full Text] [Related]
26. VEGF receptor signaling links inflammation and tumorigenesis in colitis-associated cancer.
Waldner MJ; Wirtz S; Jefremow A; Warntjen M; Neufert C; Atreya R; Becker C; Weigmann B; Vieth M; Rose-John S; Neurath MF
J Exp Med; 2010 Dec; 207(13):2855-68. PubMed ID: 21098094
[TBL] [Abstract][Full Text] [Related]
27. Utilization of Apatinib-Loaded Nanoparticles for the Treatment of Ocular Neovascularization.
Halasz K; Kelly SJ; Iqbal MT; Pathak Y; Sutariya V
Curr Drug Deliv; 2019; 16(2):153-163. PubMed ID: 30332959
[TBL] [Abstract][Full Text] [Related]
28. Apatinib strengthens the anti-tumor effect of cisplatin in thyroid carcinoma through downregulating VEGFR2.
Hu Y; Zhou N; Wang R
J BUON; 2021; 26(2):613-619. PubMed ID: 34077013
[TBL] [Abstract][Full Text] [Related]
29. In vitro and in vivo apatinib inhibits vasculogenic mimicry in melanoma MUM-2B cells.
Liu ZJ; Zhou YJ; Ding RL; Xie F; Fu SZ; Wu JB; Yang LL; Wen QL
PLoS One; 2018; 13(7):e0200845. PubMed ID: 30052652
[TBL] [Abstract][Full Text] [Related]
30. Tumor Suppression Efficacy of Heat Shock Protein 90 Inhibitor 17AAG in a Liposarcoma Mouse Model.
Nam S; Kim H; Hong D; Park JB; Kim SJ
Anticancer Res; 2017 Nov; 37(11):6291-6302. PubMed ID: 29061812
[TBL] [Abstract][Full Text] [Related]
31. Anti-tumour activity of tivozanib, a pan-inhibitor of VEGF receptors, in therapy-resistant ovarian carcinoma cells.
Momeny M; Sabourinejad Z; Zarrinrad G; Moghaddaskho F; Eyvani H; Yousefi H; Mirshahvaladi S; Poursani EM; Barghi F; Poursheikhani A; Dardaei L; Bashash D; Ghazi-Khansari M; Tavangar SM; Dehpour AR; Yaghmaie M; Alimoghaddam K; Ghavamzadeh A; Ghaffari SH
Sci Rep; 2017 Apr; 7():45954. PubMed ID: 28383032
[TBL] [Abstract][Full Text] [Related]
32. A hybrid membrane coating nanodrug system against gastric cancer
Long Y; Wang Z; Fan J; Yuan L; Tong C; Zhao Y; Liu B
J Mater Chem B; 2021 May; 9(18):3838-3855. PubMed ID: 33908580
[TBL] [Abstract][Full Text] [Related]
33. Apatinib, a Novel Tyrosine Kinase Inhibitor, Promotes ROS-Dependent Apoptosis and Autophagy via the Nrf2/HO-1 Pathway in Ovarian Cancer Cells.
Sun X; Li J; Li Y; Wang S; Li Q
Oxid Med Cell Longev; 2020; 2020():3145182. PubMed ID: 32509141
[TBL] [Abstract][Full Text] [Related]
34. Growth-suppressive activity of raloxifene on liver cancer cells by targeting IL-6/GP130 signaling.
Wang Y; Ma H; Zhao C; Liu T; Yan D; Jou D; Li H; Zhang C; Lü J; Li C; Lin J; Li S; Lin L
Oncotarget; 2017 May; 8(20):33683-33693. PubMed ID: 28430601
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic potentials of Apatinib in cancer treatment: Possible mechanisms and clinical relevance.
Fathi Maroufi N; Rashidi MR; Vahedian V; Akbarzadeh M; Fattahi A; Nouri M
Life Sci; 2020 Jan; 241():117106. PubMed ID: 31786193
[TBL] [Abstract][Full Text] [Related]
36. Thymoquinone inhibits proliferation in gastric cancer via the STAT3 pathway in vivo and in vitro.
Zhu WQ; Wang J; Guo XF; Liu Z; Dong WG
World J Gastroenterol; 2016 Apr; 22(16):4149-59. PubMed ID: 27122665
[TBL] [Abstract][Full Text] [Related]
37. Endothelial SCUBE2 Interacts With VEGFR2 and Regulates VEGF-Induced Angiogenesis.
Lin YC; Chao TY; Yeh CT; Roffler SR; Kannagi R; Yang RB
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):144-155. PubMed ID: 27834687
[TBL] [Abstract][Full Text] [Related]
38. VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2.
Zhao D; Pan C; Sun J; Gilbert C; Drews-Elger K; Azzam DJ; Picon-Ruiz M; Kim M; Ullmer W; El-Ashry D; Creighton CJ; Slingerland JM
Oncogene; 2015 Jun; 34(24):3107-19. PubMed ID: 25151964
[TBL] [Abstract][Full Text] [Related]
39. Cryptotanshinone enhances the effect of Arsenic trioxide in treating liver cancer cell by inducing apoptosis through downregulating phosphorylated- STAT3 in vitro and in vivo.
Shen L; Zhang G; Lou Z; Xu G; Zhang G
BMC Complement Altern Med; 2017 Feb; 17(1):106. PubMed ID: 28187727
[TBL] [Abstract][Full Text] [Related]
40. Total Flavones of Abelmoschus manihot Exhibits Pro-Angiogenic Activity by Activating the VEGF-A/VEGFR2-PI3K/Akt Signaling Axis.
Zhu GS; Tang LY; Lv DL; Jiang M
Am J Chin Med; 2018; 46(3):567-583. PubMed ID: 29595071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]